Back
Zevra Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
ZVRA
Zevra Therapeutics
Last Price:
$7.60
Seasonality Move:
-6.77%
7 Day Trial
ALL ACCESS PASS
$
7

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVRA is experiencing selling pressure, which indicates risk of future bearish movement.
Zevra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.86 | Sell |
20-day SMA: | 7.93 | Sell |
50-day SMA: | 7.89 | Sell |
200-day SMA: | 7.55 | Sell |
8-day EMA: | 7.75 | Sell |
20-day EMA: | 7.86 | Sell |
50-day EMA: | 7.95 | Sell |
200-day EMA: | 7.53 | Sell |
Zevra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 37.45 | Sell |
Chaikin Money Flow: | -269297 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.56 - 8.16) | Sell |
Bollinger Bands (100): | (7.76 - 8.86) | Sell |
Zevra Therapeutics Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 7.32 while ZVRA 8-day simple moving average is 7.86, which is a Sell signal.
-
The stock price of ZVRA is 7.32 while Zevra Therapeutics 20-day SMA is 7.93, which makes it a Sell.
-
Zevra Therapeutics 50-day simple moving average is 7.89 while ZVRA share price is 7.32, making it a Sell technically.
-
ZVRA stock price is 7.32 and Zevra Therapeutics 200-day simple moving average is 7.55, creating a Sell signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
24
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a SellThe current Zevra Therapeutics [ZVRA] share price is $7.32. The Score for ZVRA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
396.1M
Price in USD:
7.32
Share Volume:
398.6K
Zevra Therapeutics 52-Week Range
52-Week High:
9.76
52-Week Low:
4.20
Sell
24
Zevra Therapeutics (ZVRA)
is a Sell
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?The Zevra Therapeutics stock price is 7.32 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is overvalued.
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 7.32 while ZVRA 8-day exponential moving average is 7.75, which is a Sell signal.
-
The stock price of ZVRA is 7.32 while Zevra Therapeutics 20-day EMA is 7.86, which makes it a Sell.
-
Zevra Therapeutics 50-day exponential moving average is 7.95 while ZVRA share price is 7.32, making it a Sell technically.
-
ZVRA stock price is 7.32 and Zevra Therapeutics 200-day simple moving average is 7.53, creating a Sell signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.54 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Zevra Therapeutics is a Sell
-
Zevra Therapeutics Relative Strength Index (RSI) is 37.45, which suggest Zevra Therapeutics is oversold
-
The Bollinger Bands (25) for Zevra Therapeutics is (7.56 - 8.16), which suggest Zevra Therapeutics is a Sell
-
The Bollinger Bands (100) for Zevra Therapeutics is (7.76 - 8.86), which suggest Zevra Therapeutics is a Sell
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.